Cargando…
Conventional Therapies Do Not Prolong the Prognosis of Hepatocellular Carcinoma Patients with Extrahepatic Metastases under Receiving of Tyrosine Kinase Inhibitors
SIMPLE SUMMARY: Tyrosine kinase inhibitors (TKIs), including sorafenib and lenvatinib, have been the current standard treatment for advanced hepatocellular carcinoma (HCC) in cases where an immune checkpoint inhibitor cannot be used. The SHARP study showed that sorafenib tended to be less effective...
Autores principales: | Maeda, Hiroshi, Miura, Kouichi, Morimoto, Naoki, Watanabe, Shunji, Tsukui, Mamiko, Takaoka, Yoshinari, Nomoto, Hiroaki, Goka, Rie, Sato, Naoto, Morishima, Kazue, Sakuma, Yasunaru, Sata, Naohiro, Fukushima, Noriyoshi, Isoda, Norio, Yamamoto, Hironori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833467/ https://www.ncbi.nlm.nih.gov/pubmed/35159018 http://dx.doi.org/10.3390/cancers14030752 |
Ejemplares similares
-
Acute Liver Failure Caused by the Transmission of Hepatitis B Virus from the Spouse after 38 Years of Marriage
por: Sato, Naoto, et al.
Publicado: (2019) -
Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities
por: Miura, Kouichi, et al.
Publicado: (2022) -
Usefulness of Gd-EOB-DTPA-enhanced MRI for evaluating the potential for early
development of hepatocellular carcinoma after HCV eradication by direct-acting antiviral
treatment
por: Morimoto, Naoki, et al.
Publicado: (2019) -
Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high‐fat diet
por: Miura, Kouichi, et al.
Publicado: (2019) -
A 79-year-old Woman with Acute Hepatitis B Caused by the Infection of Subgenotype D1 Hepatitis B Virus in Japan: A Case Study
por: Hashimoto, Kosei, et al.
Publicado: (2018)